Surgical treatment of ulcers caused by extravasation of cytotoxic drugs

被引:16
作者
D'Andrea, F
Onesti, MG
Nicoletti, GF
Grella, E
Renzi, LF
Spalvieri, C
Scuderi, N
机构
[1] Univ Naples 2, Dept Plast Surg, Naples, Italy
[2] Univ Roma La Sapienza, Rome, Italy
来源
SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY | 2004年 / 38卷 / 05期
关键词
extravasation ulcer; surgical therapy; cytotoxic drugs;
D O I
10.1080/02844310410027383
中图分类号
R61 [外科手术学];
学科分类号
摘要
Despite preventive measures, the extravasation of cytotoxic drugs still occurs in 0.6% to 6% of cases. The aetiology is thought to be that tissue necrosis develops into a chronic ulcer, which causes problems if the harmful action of the drug is not blocked. From 1988-2002 at the Department of Plastic Surgery of Rome University "La Sapienza'', 240 patients presented with extravasation of cytotoxic drugs; all had been treated with an original conservative protocol first described in 1994, based on the repeated local infiltration of a large quantity of saline solution (90-540 ml) into the area of extravasation. We considered only cases with actively necrotic lesions. Eleven of the 240 patients (5%) had ulcers ranging from small ulcers to extensive areas of tissue necrosis. Of the 11 patients, eight had already had ulcers, while the remaining three were those in whom our conservative protocol had not prevented necrosis. They were all operated on and given grafts, local flaps, reverse radial flaps, and free flaps.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 32 条
[11]  
DORR RT, 1985, CANCER TREAT REP, V69, P431
[12]  
HARWOOD KV, 1984, CANCER TREAT REP, V68, P939
[13]  
HECKLER FR, 1989, CLIN PLAST SURG, V16, P557
[14]  
KJARKEGAAD K, 1990, CANCER, V65, P1722
[15]  
LARSON DL, 1990, CLIN PLAST SURG, V17, P509
[16]  
LARSON DL, 1985, PLAST RECONSTR SURG, V75, P397, DOI 10.1097/00006534-198503000-00017
[17]   TREATMENT METHODS FOR EXTRAVASATIONS OF CHEMOTHERAPEUTIC-AGENTS - A COMPARATIVE-STUDY [J].
LOTH, TS ;
EVERSMANN, WW .
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1986, 11A (03) :388-396
[18]  
LUCERO MJ, 1993, PHARMAZIE, V48, P772
[19]  
Morykwas MJ, 1999, J SURG ONCOL, V72, P14, DOI 10.1002/(SICI)1096-9098(199909)72:1<14::AID-JSO4>3.0.CO
[20]  
2-3